This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Centers for Disease Control and Prevention is seeking public comments on how Americans with chronicpain are successfully treating their symptoms. CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.”
A team of Israeli researchers conducted a randomized placebo-controlled clinical trial to assess the safety and efficacy of a novel, metered-dose cannabis inhaler in 27 patients with chronicpain. Chronicpain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs.
Today, Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act , to expand and facilitate medical cannabis access to military veterans suffering from chronicpain, PTSD, and other serious medical conditions.
You may get relief without side effects associated with traditional pain medications. Patients dealing with chronicpain from numerous conditions are finding relief in cannabis. Navigating the journey of medical cannabis for chronicpain involves understanding: How it works in the body.
A Guide to Choosing Cannabis Strains for ChronicPain Relief The use of cannabis to treat chronicpain is becoming increasingly popular among patients seeking alternative treatments for their symptoms. What are the Best Cannabis Strains for ChronicPain? What are the Cannabinoids Found in Cannabis?
In adults with chronicpain , what are the harms of Kratom or other plant-based substances for treatment of chronicpain? In adults with chronicpain, what are the harms of cannabinoids? In adults with chronicpain, what are the benefits of cannabinoids?
Chronicpain affects millions of people worldwide, significantly impacting their quality of life and often leading to the development of other health conditions. Standard medical treatments, including opioids and over-the-counter pain relievers, often provide limited relief and may carry the risk of addiction or adverse side effects.
Senate Bill 406 expands medical cannabis access and provides important new patient protections. The measure prohibits regulators from placing limits on the percentage of THC or other cannabinoids in therapeutic products and it establishes reciprocity with other states’ medical cannabis programs. MEDICAL CANNABIS.
Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.
The study, titled Pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronicpain: A randomized, double-blinded, placebo-controlled trial , was first published by NORML. “The 1mg dose showed a significant pain decrease compared to the placebo. .”
We will be exploring cannabis therapy for chronic conditions. Note that chronicpain refers to the persistent or long-lasting discomfort in the body beyond the normal time frame for healing. The ways chronicpain manifests varies and includes musculoskeletal pain affecting the muscles, bones, ligaments, tendons, and joints.
In recent years, there has been a growing interest in the therapeutic potential of medical marijuana, particularly in its ability to provide relief for individuals grappling with chronicpain. Among its various applications, one of the most prominent is its effectiveness in alleviating pain.
This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.
She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to ChronicPain. Dr. Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session.
Chronicpain can affect the quality of life of an individual as it usually comes with severe discomfort that lasts for days or weeks. Fortunately, you can alleviate this pain by using proper medication. However, most of these pain-relieving drugs come with side-effects. Instead, it helps to ease pain and inflammation.
So this is a huge improvement and will make the process much easier for those looking to access medical cannabis in Virginia,” said Jenn Michelle Pedini, Executive Director for Virginia NORML. The latest changes to Virginia’s medical cannabis law adds to a growing list of amendments aimed at improving patient access. Chronicpain.
In this article, we explore how medical marijuana for multiple sclerosis symptoms helps patients, with its diverse cannabinoid components, alleviate MS symptoms, and enhance the quality of life for patients. Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, specifically the brain and spinal cord.
Let’s go over the three main components of ECS to better understand, they are: endocannabinoids, cannabinoid receptors, and enzymes. Endocannabinoids are synthesized on demand in response to changes in cellular activity and play a key role in regulating various functions, such as mood, appetite, pain sensation, and memory.
Medical marijuana, with its diverse range of cannabinoids and potential health benefits, has emerged as a subject of interest in the context of women’s health. Many women navigate conditions like chronicpain, autoimmune disorders, and inflammatory conditions that can impact their physical quality of life.
There have been some studies around cannabinoids and certain terpenes effects on sleep, but most of this research is preclinical, which means it’s not tested on humans yet. A chemotype is a grouping of cannabis varieties based on their chemical composition, organized by its most dominant cannabinoid. THC and sleep.
Through community outreach, social media campaigns, educational seminars, and mental health screenings, the month seeks to empower individuals to seek help when needed, cultivate supportive environments, and advocate for policies that promote mental health equity and access to care.
There are limited treatment options for those who suffer from this condition, and many of those who do have access to treatment have found it difficult or impossible to obtain insurance coverage for their care because marijuana is still illegal on the federal level in the U.S. There are over 140 cannabinoids in the cannabis plant.
In talking about cannabis and its uses, a lot of attention is always paid to THC, the most well known cannabinoid in the cannabis plant. THC is primarily responsible for the psychoactive effects users feel, and it also helps to combat nausea, increase appetite, encourage sleep, and relieve chronicpain.
Recent research reaffirms earlier studies that claim that certain non-marijuana plants contain similar compounds found in cannabis, often called cannabinoids. Being a common weed across Brazil, Trema Micrantha may offer a more accessible, less stigmatized, and cheaper CBD source to the consumers’ community.
Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). Health Europa reports. PROGRAMME.and.ABSTRACTS.
However, with medical cannabis continuing to spread through the country—and with more and more research pointing to its benefits for everything from chronicpain and sleep problems to anxiety and arthritis—the tide seems to be turning. Numerous studies point to that fact, especially in cases surrounding chronicpain and discomfort.
The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod. Kanabo’s medical line aims to enable patients to move away from the harmful habit of smoking medical cannabis flowers.
Now, he is the Vice-Chair of Indiana NORML — an organization who is currently focused on changing cannabis laws for the access to Medical Cannabis as therapeutic treatment in Indiana. ISNA POSITION STATEMENT AND BACKGROUND: Therapeutic Use of Marijuana and Related Cannabinoids—. ISNA 2020- Jason Straw- Medical Cannabis Policy.
Marinol, also known as Dronabinol, is a medication used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy, loss of appetite and weight loss in people with HIV/AIDS, as well as chronicpain. By binding to CB1 receptors, Marinol mimics the effects of naturally occurring cannabinoids in the body.
The dispensary will sell a variety of cannabinoids, including flower, vapes, edibles, and topicals. aims to provide patients with safe and regulated access to medicinal cannabis products,” Qualla Enterprises wrote in their official press release. With a commitment to quality, compassion, and education, Great Smoky Cannabis Co.
The Louisiana Department of Health recently notified businesses about an opportunity to obtain a license for making foods that contain cannabinoids. Consumable hemp is defined as “any product derived from industrial hemp that contains any cannabinoids and is intended for consumption or topical use.”
One particular study featured in the 2019 edition of the American Journal of Psychiatry found that the cannabinoid CBD may ease drug cravings and feelings of anxiety in heroin addicts. Taking this into account, it is unsurprising that Canadians with legal cannabis access are using the plant to help them quit using more harmful substances. “As
It wasn’t until the movement by thousands of patients and patient advocates in the 1990’s that propelled the government to allow fair access to medical marijuana. Due to uncertainty and lack of controlling measures, the government further restricted medical cannabis access by preventing patients from having growing privileges.
When dealing with chronicpain, finding relief can be a daily struggle for many people. Traditional pain medications often come with a slew of side effects and may not even provide adequate relief. Medicinal marijuana offers a natural and effective way to manage pain, with fewer adverse effects than traditional medications.
The limit on where scientists could access cannabis for research was limited to just one facility at the University of Mississippi. But what does new access to medical marijuana for scientific research in the United States mean for medical marijuana development? Cannabinoid research and development. The roadblocks ahead.
Chronicpain conditions, such as arthritis or back pain, can cause discomfort that interferes with sleep. Medical marijuana refers to the use of cannabis and cannabinoids for medical purposes, such as using cannabis for insomnia relief, to alleviate symptoms, or to treat conditions under medical supervision.
While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronicpain, nausea, appetite loss, and psychological distress. Derived from the Cannabis plant, it contains cannabinoids like tetrahydrocannabinol (THC) and cannabidiol (CBD).
As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronicpain but were unable to answer their patients’ questions” (1).
What influences chronicpain patients’ use of medical cannabinoids? The British Medical Journal recently published results of a systematic review that explored values and preferences towards medical cannabis (MC) among people living with chronicpain. doi: 10.1136/bmjopen-2021-050831.
The demand for cannabinoid medicine has never been more evident after the release of a YouGov poll suggesting that millions of British citizens are illegally using street cannabis to treat chronic health conditions. Increasing demand for medical cannabis.
A new 2023 study published in the journal Medical Cannabis and Cannabinoids revealed that using a THC/CBD spray can help significantly reduce chronic back and neck pain. This exciting development could have profound implications for how we approach managing this type of pain.
PTSD can have far-reaching effects on health, functionality as well as on quality of living, which is why having access to effective treatment is so important. Cannabinoids & Terpenes for PTSD. Purchasing the cannabis bud (the flower) will be optimal because it allows you to benefit from the terpenes and all the cannabinoids.
Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). 1 Simultaneously, the AAFP acknowledges preliminary evidence indicates marijuana and cannabinoids may have potential therapeutic benefits, while also recognizing subsequent negative public health and health outcomes associated with cannabis use.
Treatment with medical cannabis is an emerging therapy for different pathologies according to Millard, such as in cases of multiple sclerosis, nausea induced by chemotherapies, in addition to alleviating chronicpain. He explained that the drugs would come to the country in oral presentation through capsules or sublingual drops.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content